mpeg-alkyne (mw 1000)

mPEG-Alkyne (MW 1000) is a polyethylene glycol (PEG) derivative. The alkyne group can undergo chemical reactions with azides in aqueous solutions in the presence of a monovalent copper catalyst. PEG derivatives enhance drug solubility and stability, reduce peptide immunogenicity, and offer excellent biocompatibility.

mPEG-Alkyne (MW 5000) is a PEG derivative that can undergo a chemical reaction with azides in aqueous solutions under the catalysis of monovalent copper. Polyethylene glycol derivatives enhance drug solubility and stability, reduce the immunogenicity of polypeptides, and possess excellent biocompatibility.

mPEG-Alkyne (MW 2000) is a PEG derivative. Under the catalysis of monovalent copper, the alkyne group can chemically react with azides in an aqueous solution. Polyethylene glycol derivatives can enhance drug solubility and stability, reduce the immunogenicity of peptides, and exhibit excellent biocompatibility.

mPEG-Alkyne (MW 10000) is a PEG derivative that undergoes a chemical reaction with azides in an aqueous solution in the presence of a monovalent copper catalyst. This polyethylene glycol derivative enhances the solubility and stability of drugs, reduces the immunogenicity of peptides, and possesses excellent biocompatibility.

mPEG-Alkyne (MW 3400) is a PEG derivative. Under the catalysis of monovalent copper, the alkyne reacts chemically with azide in aqueous solution. Polyethylene glycol derivatives enhance drug solubility and stability, reduce the immunogenicity of polypeptides, and offer excellent biocompatibility.

mPEG-Alkyne (MW 20000) is a PEG derivative. Under the catalysis of a monovalent copper, the alkyne group can chemically react with azide in an aqueous solution. Polyethylene glycol derivatives enhance drug solubility and stability, reduce peptide immunogenicity, and exhibit excellent biocompatibility.

mPEG-Alkyne (MW 40000) is a PEG derivative capable of undergoing a chemical reaction with azides in aqueous solutions in the presence of a monovalent copper catalyst. Polyethylene glycol derivatives are known to enhance drug solubility and stability, reduce the immunogenicity of peptides, and possess excellent biocompatibility.